THNR

Technical Sentiment Analysis for Amplify Weight Loss Drug & Treatment ETF (THNR). As of 2026-03-04, Amplify Weight Loss Drug & Treatment ETF (THNR) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 5 indicators are flashing buy, while 7 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for THNR stands at 41.86, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.14, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 18.36 and the Commodity Channel Index (CCI) at -146.11 further confirm a -1.12 outlook for the ETF.

Support, Resistance & Moving Averages. From a structural perspective, THNR is trading above its 60-day moving average of $25.86 and above its 200-day long-term moving average of $24.09. Key price levels to watch include the immediate resistance at $26.78 and strong support at $24.94. A break above $26.78 could signal a bull continuation, while falling below $24.94 may test the next Fibonacci floor at $23.98.